Aurobindo Pharma Share Price, Technical, Fundamental Analysis, Financials, Shareholding, RSI, MACD and Moving Averages
Price on NSE
Price on BSE
Aurobindo Pharma (AUROPHARMA (BSE Code: 524804)) Key Ratios
Aurobindo Pharma Share Price Analysis Local DB
Aurobindo Pharma share price is ₹1,648.20, day high (share price) is ₹1,695.00, day low (share price) is ₹1,639.60 and volume is 816,419. 52 Week high share price for Aurobindo Pharma is ₹1,717.00 on 31 Aug 2026 and 52 week low share price for Aurobindo Pharma is ₹1,016.10 on 01 Sep 2025. Price data as of: 02 Sep, 2026 3:31 PM.
According to latest price data (as of 02 Sep, 2026 3:31 PM) for Aurobindo Pharma share, 14 day period RSI (Relative Strength Index) is 54.2, 50 DMA (50 Displaced Moving Average) is 1,594.13 and 200 DMA (200 Displaced Moving Average) is 1,367.43.
Aurobindo Pharma (AUROPHARMA) Technical Analysis
Aurobindo Pharma Technical Data and Analysis available in multiple timeframes.
Aurobindo Pharma Oscillators Analysis
Aurobindo Pharma Price Action
Aurobindo Pharma Oscillators Overview
| Indicator | Value |
|---|---|
| RSI (14) | 54.23 |
| Stoch %K (14, 3, 3) | 71.09 |
| CCI (20) | 74.16 |
| ADX (14) | 27.60 |
| Awesome Osc | 51.85 |
| Momentum (10) | 23.70 |
| MACD (12, 26, 9) | 22.09 |
| MACD Signal | 20.60 |
| Stoch RSI (14) | 57.49 |
| Williams %R (14) | -58.21 |
| Bull/Bear Power | 43.38 |
| Ultimate Osc | 57.67 |
| MFI (14) | 49.00 |
| ROC (21) | 3.93 |
| ROC (125) | 35.05 |
| ATR (14) | 39.67 |
Aurobindo Pharma Moving Averages
| Ichimoku Base | 1,626.90 | Above Base |
| VWMA (20) | 1,646.35 | Above VWMA |
| HMA (9) | 1,695.29 | Below HMA |
Aurobindo Pharma Technical SWOT Analysis
STRENGTHS
- Price is trading above the 200 DMA, indicating relatively stronger long-term positioning.
- Price is above the 50 DMA, suggesting supportive medium-term trend structure.
- MACD is above the signal line and in positive territory, reflecting supportive momentum.
- RSI at 54.23 reflects mild positive momentum.
WEAKNESSES
- No notable technical weakness signals are currently observed.
OPPORTUNITIES
- No specific opportunity signals are identified; the setup appears neutral.
THREATS
- No immediate technical risk signals are identified.
Aurobindo Pharma Daily Pivot Points (Support & Resistance)
| Level | Classic | Woodie's | Camarilla | Fibonacci |
|---|---|---|---|---|
| Resistance 3 | 1,727.57 | 1,718.50 | 1,691.28 | 1,713.83 |
| Resistance 2 | 1,713.83 | 1,709.30 | 1,688.62 | 1,702.76 |
| Resistance 1 | 1,698.57 | 1,689.50 | 1,685.96 | 1,695.91 |
| Pivot Point | 1,684.83 | 1,680.30 | 1,683.30 | 1,684.83 |
| Support 1 | 1,669.57 | 1,660.50 | 1,680.64 | 1,673.76 |
| Support 2 | 1,655.83 | 1,651.30 | 1,677.98 | 1,666.91 |
| Support 3 | 1,640.57 | 1,631.50 | 1,675.33 | 1,655.83 |
| Date | Close | ADX | PDI | MDI | Aroon Up | Aroon Down | Bollinger UB | Bollinger MB | Bollinger LB | CCI | CMF | MACD | Signal | MFI | PSAR | RSI (F) | RSI | Sto (F) %K | %D | Supertrend | Ult Osc | Wil %R |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Synchronizing oscillators history... | ||||||||||||||||||||||
| Date | Close | SMA(5) | EMA(5) | SMA(8) | EMA(8) | SMA(9) | EMA(9) | SMA(10) | EMA(10) | SMA(12) | EMA(12) | SMA(20) | EMA(20) | SMA(21) | EMA(21) | SMA(26) | EMA(26) | SMA(30) | EMA(30) | SMA(34) | EMA(34) | SMA(50) | EMA(50) | SMA(100) | EMA(100) | SMA(150) | EMA(150) | SMA(200) | EMA(200) | Ichimoku Base | VWMA(20) | HMA(9) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Synchronizing moving averages history... | ||||||||||||||||||||||||||||||||
Aurobindo Pharma - Shareholding Pattern
Historical breakdown of ownership percentages over time.
| Category | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 |
|---|---|---|---|---|
| Promoters | 51.88% | 51.82% | 51.82% | 51.82% |
| FII | 16.38% | 15.24% | 13.94% | 14.21% |
| DII (Other) | 8.39% | 8.08% | 8.17% | 8.30% |
| Retail & Others | 6.64% | 7.08% | 6.55% | 6.38% |
| Mutual Funds | 16.71% | 17.79% | 19.52% | 19.30% |
Aurobindo Pharma - Yearly Income Statement (in ₹ Crore)
| Period | Revenue | Operating Profit | Net Profit |
|---|---|---|---|
| Mar 2026 | 34,145.17 +5.56% | 5,111.85 +0.9% | 3,502.97 +0.56% |
| Mar 2025 | 32,345.58 +9.43% | 5,066.29 +15.67% | 3,483.57 +9.93% |
| Mar 2024 | 29,559.25 +17.55% | 4,379.99 +67.66% | 3,168.97 +64.4% |
| Mar 2023 | 25,145.97 | 2,612.50 | 1,927.65 |
Aurobindo Pharma - Corporate Actions
| Type | Ex-Date | Amount / Ratio | Details |
|---|---|---|---|
| Dividend | 08 Aug 2025 | ₹4 | View Details |
|
Announcement date
04 Aug 2025
Ex dividend date
08 Aug 2025
Record date
08 Aug 2025
Dividend type
Interim
Amount
4.0
Dividend %
400.0
Details
Rs.4.0000 per share(400%)Interim Dividend
|
|||
